Shandong Weigao Group Medical Polymer Company Limited

Equities

1066

CNE100000171

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. 04:08:35 2024-04-19 am EDT 5-day change 1st Jan Change
4.76 HKD -0.42% Intraday chart for Shandong Weigao Group Medical Polymer Company Limited 0.00% -37.45%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Weigao Group Logs 28% Decline in 2023 Profit MT
Shandong Weigao Group Medical Polymer Company Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 12 July 2024 CI
Shandong Weigao Group Medical Polymer Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Weigao Orthopaedic Device's Chairman Resigns MT
Nomura Adjusts Shandong Weigao Group Medical Polymer’s Price Target to HK$8.45 From HK$9.91, Keeps at Buy MT
Shandong Weigao Group Medical Polymer Company Limited Provides Earnings Guidance for the Year Ended 31 December 2023 CI
Shandong Weigao Group Medical Polymer Company Limited Announces the Resignation of Ni Has Tendered as Executive Director, Effective from 31 December 2023 CI
Crown International Chairman Resigns; Successor Named MT
Shandong Weigao Group Medical Polymer Company Limited Approves Interim Dividend for the Six Months Ended 30 June 2023, Payable on 24 November 2023 CI
Shandong Weigao to Allot Over 97 Million Shares to Staffers MT
Weigao Group Medical Polymer Slashes Dividend as H1 Profit Declines 16% MT
Shandong Weigao Group Medical Polymer Company Limited Proposes Interim Dividend for the Six Months Ended 30 June 2023, Payable on 24 November 2023 CI
Shandong Weigao Group Medical Polymer Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Shandong Weigao Flags Up to 19% Fall in H1 Profit MT
Shandong Weigao Group Medical Polymer Company Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023 CI
Nomura Adjusts Shandong Weigao's Price Target to HK$13.26 From HK14.79, Keeps at Buy MT
Shandong Weigao Group Medical Polymer Company Limited Approves Final Dividend for the Year Ended 31 December 2022, Payable on or Before 14 July 2023 CI
Nomura Adjusts Shandong Weigao Group Medical Polymer's Price Target to HK$14.79 From HK$15.90, Keeps at Buy MT
Weigao Group Logs 14% Rise in 2022 Profit MT
Shandong Weigao Group Medical Polymer Company Limited Proposes Ordinary Final Dividend for the Year Ended December 31, 2022, Payable on 14 July 2023 CI
Shandong Weigao Group Medical Polymer Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Shandong Weigao Orthopaedic Device's 2022 Profit Down 20.8% MT
Nomura Adjusts Shandong Weigao Group Medical Polymer's Price Target to HK$15.90 From HK$13.33, Keeps at Buy MT
Shandong Weigao to Buy Medical Equipment Developer for 1 Billion Yuan MT
Shandong Weigao Group Medical Polymer Company Limited completed the acquisition of Weihai Weigao Medical Materials Company Limited from Weigao Holding Company Limited. CI
Chart Shandong Weigao Group Medical Polymer Company Limited
More charts
Shandong Weigao Group Medical Polymer Co., Ltd. is principally engaged in the research and development, production and sale of single-use medical devices. The Company sells products under brand names of Jierui and Wego Ortho. The Company operates through three business segments. The Single Use Medical Device Products segment is engaged in the production and sale of single-use consumables, such as infusion sets, syringes, blood transfusion sets and blood bags. The Orthopaedic Products segment is engaged in the production and sale of orthopaedic products. The Blood Purification Products segment is engaged in the production and sale of blood purification products and related medical equipment. The Company is also engaged in the manufacture of industrial automatic equipment and parts, as well as the provision of logistics and storage services through its subsidiaries.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
4.418 CNY
Average target price
8.129 CNY
Spread / Average Target
+83.99%
Consensus
  1. Stock Market
  2. Equities
  3. 1066 Stock
  4. News Shandong Weigao Group Medical Polymer Company Limited
  5. Shandong Weigao Medical Polymer : Weigo Group's Unit to Acquire Wego Healthcare Fund for $190 Million; Shares Jump 3%